Nanjing Synthgene Medical Technology Co., Ltd. is a high-tech enterprise focusing on the development, production of in vitro diagnostic (IVD) materials and POCT diagnostic reagents. The company has advanced technology platforms, including protein expression and purification platforms, hybridoma monoclonal antibody screening platforms, antibody engineering design platforms, etc., which provide a solid technical foundation for the development of diagnostic antibodies.
At the same time, our company currently has fluorescence chromatography platform and latex turbidity platform. We are committed to promoting the accurate diagnosis of human diseases with high-quality diagnostic products and contributing to the cause of human health.
Synthgene's manufacturing system meets GMP standards for medical devices, and is certified with ISO13485 by UKAS. Relevant in vitro diagnostic reagent products have obtained the EU CE certification. Synthgene is also a member on the "allow list" issued by Chinese Ministry of Commerce for anti-epidemic products exporting POCT kits, which have been recognized by customers around the world.
